Hrt Financial LP Ovid Therapeutics Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$3.13 - $3.73 $358,363 - $427,058
-114,493 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.31 - $4.04 $56,342 - $68,768
-17,022 Reduced 12.94%
114,493 $384,000
Q2 2021

Aug 16, 2021
BUY
$3.3 - $4.49 $433,999 - $590,502
131,515 New
131,515 $514,000

Others Institutions Holding OVID

# of Institutions
75
Shares Held
39M
Call Options Held
37.4K
Put Options Held
500
View Full List

About Ovid Therapeutics Inc.

OVID Quotes by TradingView
  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $73.9M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email